Found 0 matching trials
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
PHASE2This is a Phase II, open-label, two strata, multicenter, prospective study ...
Location
H. Lee Moffitt Cancer Center
High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML
PHASE2The purpose of this study is to determine the effectiveness of a particular...
Location
The University of Chicago
Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases
PHASE1While glucocorticoids and immunosuppressants ameliorate manifestations of a...
Location
Charité Universitätsmedizin Berlin
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
PHASE3The purpose of the study is to assess the safety and efficacy of targeted i...
Location
Multiple Locations
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
PHASE2Patients included in the study will receive induction treatment during 6 mo...
Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona
Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies
PHASE1This single arm pilot phase I study with safety run-in is designed to estim...
Location
Washington University School of Medicine
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
PHASE1This is an open-label, single-arm, multicenter, Phase 1/2 study evaluating ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation
PHASE1This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Treatment of Gingival Recessions with Connective Tissue or Concentrated Growth Factor Membrane Using Tunnel Technique
NAThis randomized controlled clinical study aimed to evaluate the success of ...
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
NAThis clinical trial studies peripheral blood hemapoietic stem cell mobiliza...
Location
Barbara Ann Karmanos Cancer Institute